Back to Top

Informing, inspiring, and advancing global innovation to support a healthy, sustainable future

For Immediate Release

Vaccine Use in Pregnancy: Deferring Risk

Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com

New Rochelle, NY, July 13, 2022—Existing gaps and serious limitations concerning the information in vaccine product labels makes it challenging for healthcare providers to know when to recommend vaccination to pregnant women. A new study, which identified these knowledge gaps, surveyed healthcare providers, and recommended improvements for the future is published in the peer-reviewed Journal of Women’s Health. Click here to read the article now.

Healthcare providers are often hesitant to recommend vaccination in pregnancy, and this hesitancy has been linked to inconsistencies and ambiguity in vaccine information, evidence, and policies, including information in vaccine labels. In their survey, Janice Graham, PhD, from Dalhousie University and the Canadian Center for Vaccinology, and coauthors, showed that healthcare providers were uncertain about the purpose of vaccine product labels and the evidence contained in them. More than a third of the survey respondents incorrectly thought that the information contained in the product labels was updated regularly. “Most healthcare providers were unaware that labels are not up-to-date about the risks or burden of the disease,” state the investigators.

“More frequent updating and alignment of robust, unbiased, and independently reviewed clinical trial and post-market safety and effectiveness evidence with Nation Immunization Technical Advisory Group recommendations would allay health care providers and public misunderstanding,” conclude the investigators.

“For the COVID-19 vaccines, specifically, there are no data about pregnancy and breastfeeding included in the labeling. As noted by the authors, despite the growing body of evidence about the use of COVID-19 vaccines and the risk of severe disease from COVID-19, there is no indication if/when those vaccine labels will be updated,” says Journal of Women’s Health Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA.

About the Journal

Journal of Women’s Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. Led by Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA, the Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women’s healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women’s Health website. Journal of Women’s Health is the official journal of the Society for Women’s Health Research.

About the Publisher

Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s more than 100 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com